Skip to Main Content

Paper Details

Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism: 2022 updated systematic review and meta-analysis of randomized controlled trials.
J Hematol Oncol
22
2022
Author NameAffiliation
Deborah SchragMemorial Sloan Kettering Cancer Center
  • 1 - 1

Datasets

Release 1.2